Table 3.

Between-group comparisons on asthma variables

	Baseline	Mid	Post	Cohen’s d	3 MFU	Cohen’s d	Group p	Time p	Group x Time p
MARS							.52	<.0001	.01
CBPT	3.51 (0.17)	4.39 (0.18)	4.38 (0.18)***	0.96	4.43 (0.17) ***	1.17
MRT	4.15 (0.17)	4.33 (0.19)	4.40 (0.20)	0.47	4.37 (0.19)	0.52
ACQ							.47	<.0001	.54
CBPT	0.85 (0.14)	0.46 (0.16)	0.22 (0.17)***	−0.83	0.37 (0.16)**	−0.53
MRT	0.85 (0.15)	0.73 (0.17)	0.46 (0.18)*	−0.71	0.39 (0.18)**	−0.63
%FEV1							.59	.0002	.57
CBPT	70.90 (3.48)	72.84 (3.59)	75.44 (3.62)*	0.45	73.27 (3.59)	0.21
MRT	70.73 (3.71)	76.12 (3.79)	78.64 (3.86)***	0.82	77.10 (3.87)**	0.86
AQLQ							.67	<.0001	.57
CBPT	3.15 (0.27)	3.96 (0.30)	4.67 (0.32)***	0.93	4.69 (0.30)***	0.93
MRT	3.36 (0.28)	3.82 (0.32)	4.28 (0.34)**	0.80	4.43 (0.33)**	0.85
%Good control, rescue medication							.72	.19	.80
CBPT	28.99 (10.69)	49.72 (11.79)	55.42 (12.83)		65.15 (11.91)*
MRT	23.24 (9.69)	55.09 (12.06)	51.48 (13.36)		40.02 (12.65)

Notes. Mean (SE), adjusted values reported

ACQ data represent natural logarithm transformation and lower scores = better control

Within-group comparisons are denoted by * p < .05 ** p < .01 *** p < .001 and are reported for post-treatment and 3-month follow-up versus baseline

Effect sizes reported for within-group change